Argentum is dedicated to supporting innovative and cost effective treatment options for patients, by acquiring, developing and marketing new generic drugs.
Use this information to figure out if this company is an ideal customer for you.
703.282.0524
134 Spring Street
New York, 10012
Argentum Pharmaceuticals's CEO is Paul Strain
Argentum Pharmaceuticals's CFO is Stephan Schulze
Argentum Pharmaceuticals's HQ is located at 134 Spring Street, New York
Argentum Pharmaceuticals's phone number is 703.282.0524
Argentum Pharmaceuticals's official website is argentumpharmaceuticals.com
Argentum Pharmaceuticals's revenue is $1M - $5M
Argentum Pharmaceuticals has 11 - 50 employees
Argentum Pharmaceuticals is in the industry of: Pharmaceuticals